header logo image


Page 926«..1020..925926927928..940950..»

New tool for cell-free therapy based on artificial membrane vesicles – Medical Xpress

August 29th, 2017 2:43 am

Scientists at Kazan Federal University's Institute of Fundamental Medicine and Biology, led by Professor Albert Rizvanov, have shown that artificial membrane vesicles generated by Cytochalasin B treatment of human cells retain angiogenic activity.

Vesicles are small packages of material released from cells and act to deliver cargo and messages to adjacent and distant cells. Vesicles are known to be important regulators of normal physiology and have also been implicated in disease, notably cancer. Extracellular vesicles exhibit the biological activity of the cell from which they originate. For example, extracellular vesicles of stem cells are able to promote angiogenesis and regeneration. For this reason, extracellular vesicles represent a promising tool for cell-free therapy to deliver biologically active molecules.

However, the yield of naturally occurring vesicles is too low for practical purposes. Recently, several studies demonstrated the ability to generate a large number of membrane vesicles from cultured cells treated with a drug, Cytochalasin B. This cost-effective approach permits the generation of large quantities of extracellular vesicles. However, it remained unknown whether these Cytochalasin B-induced micro-vesicle (CIMVs) retained characteristic biological properties of their parental cells.

To address this, an international team of investigators, led from Kazan Federal University, Russia by Professor Albert Rizvanov, with international collaborators, characterized the biological activity of membrane vesicles.

The study was published in Oncotarget. The lead author, Dr. Marina Gomzikova, and colleagues described the morphology, molecular composition, fusion capacity and biological activity of Cytochalasin B-induced membrane vesicles (CIMVs). This data suggests that the biophysical, molecular and size distribution properties of CIMVs are similar to natural vesicles. Furthermore, they demonstrated that CIMVs retain the biological properties of the donor cells, as they can stimulate angiogenesis in vitro and in vivo.

CIMVs can now be produced in large quantities and scaled to an industrial production level; potential therapeutic applications to deliver biologically active molecules of CIMVs are now possible.

Explore further: Insulin release is controlled by the amount of Epac2A at the secretory vesicles

More information: Cytochalasin B-induced membrane vesicles convey angiogenic activity of parental cells. Oncotarget. doi.org/10.18632/oncotarget.19723

Read more:
New tool for cell-free therapy based on artificial membrane vesicles - Medical Xpress

Read More...

Fish consumption and rheumatoid arthritis: Natural remedy or just another fish tale? – Harvard Health (blog)

August 29th, 2017 2:42 am

Follow me on Twitter @RobShmerling

When I see patients with rheumatoid arthritis, Im often asked about diet. Are there foods that can help? Should I avoid certain foods?

Whenever Im asked about diet for arthritis, my short answer is that with a few exceptions, there is no proven role for making dietary changes. In the case of rheumatoid arthritis, there is no clear evidence that eating more (or less) of any particular food will improve (or worsen) their symptoms or protect their joints. Of course, new research could change my answer.

And what about the exceptions? The most important is probably gout. Certain foods and beverages (such as organ meats and alcohol) can predispose to the condition or make it worse. Most people with gout are told to modify their diets, although for most the impact is small.

There is enormous interest now in the role of the microbiome the vast numbers of microorganisms living within us in health and disease. And we know that diet affects the microbiome within the intestinal tract. It could turn out that what you eat may cause certain populations of bacteria in the intestinal tract to rise or fall. Since these bacteria may affect immune function, and since rheumatoid arthritis is an autoimmune condition, its possible that changes in the microbiome will affect the activity and severity of rheumatoid arthritis. Researchers are working hard to understand how the microbiome might affect autoimmune diseases, and how this new perspective could lead to better control of conditions such as rheumatoid arthritis.

A number of studies have found that fish oil supplements or a diet rich in fish oils may be helpful in controlling the inflammation of rheumatoid arthritis. In addition, its possible higher intake of fish oil actually reduces the likelihood of developing the disease. Some studies have found that rheumatoid arthritis is less common in places where fish consumption is highest. However, fish oil is not routinely recommended, because its effect is modest and medications tend to be much more effective.

A new study resurrects the idea that fish oil (or at least fish consumption) might suppress the joint inflammation of rheumatoid arthritis. Researchers publishing in the medical journal Arthritis Care & Research report that the more fish a person consumes, the better the control of their arthritis. In this study, researchers analyzed data from 176 people with rheumatoid arthritis, comparing their reported intake of non-fried fish with the results of their joint examinations and blood tests. Heres what they found:

This was a small study that found an association between fish consumption and control of rheumatoid arthritis. Thats not the same as finding that fish intake actually caused the improvement in arthritis. This is an important point because factors other than diet could explain the findings. For instance, its possible that people who eat fish regularly are generally more attuned to their health and take their medications more reliably than people who eat fish less often. Thats why the authors of this study do not conclude that everyone with rheumatoid arthritis should start eating more fish. What they do say is that additional research is needed.

One other point: the improvement in arthritis control noted among those who ate the most fish was modest, and so small that most patients probably wouldnt notice. Still, small improvements can add up, so even a small effect from a natural remedy that poses minimal risk is worth consideration.

Im hopeful that in the near future well have more definitive, larger, and long-term studies that examine the role of diet on rheumatoid arthritis and other types of joint disease. Until then, I think people with rheumatoid arthritis should consider increasing their intake of non-fried fish. It might be good for the joints. And eating fish may have other health benefits as well, especially if it replaces less healthy choices.

Go here to see the original:
Fish consumption and rheumatoid arthritis: Natural remedy or just another fish tale? - Harvard Health (blog)

Read More...

In a first, scientists may have found a treatment for heart disease that doesn’t target cholesterol – Quartz

August 29th, 2017 2:42 am

Almost every drug on the market for heart disease targets cholesterol. So it was major news on Aug. 27 when a group of cardiologists from around the world announced theyd discovered a drug that reduces inflammationand currently used to treat juvenile arthritissuccessfully prevented heart attacks, strokes, and other kinds of cardiac death in a recent trial.

The drug is called canakinumab and sold under the brand name Ilaris by the Swiss company Novartis, which funded the study. It works to treat juvenile arthritis by reducing the number of inflammatory chemicals in the blood called interleukin-1.

The new study, published in the New England Journal of Medicine, involved over 10,000 patients living in 39 countries who were at a higher risk of heart disease. Each had a history of heart attacks and high levels of interleukin-1 in their blood; 40% of the patients also had diabetes. Patients were randomly put in four groups and received either a placebo, 50 milligrams, 150 milligrams, or 300 milligrams of canakinumab every two weeks of the first month, and then once every three months through an injection for up to four years after.

Throughout the study, researchers also kept track of heart attacks, strokes, and death resulting from heart failure. By the end of the study, there were just over 1,400 reported incidents of these events; the patients receiving the highest dose of canakinumab had 14% fewer of them than the placebo group.

For years, cholesterol was thought to be the hormonal villain associated with heart disease. The idea was that it would clog up arteries by clumping against the sides of blood vessels, making it impossible for blood to squeeze through. Doctors were hugely excited when cholesterol-lowering statins were invented back in 1994; these drugs are now prescribed to tens of thousands of Americans with the hope that they will keep heart disease at bay.

But lowering cholesterol doesnt seem to prevent heart disease in every patient. So now experts believe high interleukin-1 blood levels can also be responsible for raising heart attack risk. The general thinking is that these inflammatory chemicals end up preventing the heart from healing from damage from previous heart heart attacks. This extra stiffening and swelling may put an extra strain on it in the future, too.

Interleukin-1 isnt all bad; we need it to survive injury or other infections. The chemical works by forcing damaged tissue to swell up with extra fluid from blood vessels, in order to isolate potential pathogens before they make their way all over the body. But interleukin-1 tends to be a little trigger-happy, and can sometimes cause inflammatory reactions that are more harmful than helpful, especially in certain chronic diseases like arthritis, and now, possibly, heart disease.

Interestingly, different results from the same trial suggesting that this therapy may even work to extend the lives of patients living with lung cancer were published in a paper the same day in The Lancet. That said, Barnett Kramer, the director of the Division of Cancer Prevention at the National Cancer Institute who was not associated with the work, told the Washington Post that these effects may be coincidental.

The drug itself is not likely to be a miracle cure. In both papers, those taking canakinumab were at a higher risk of dying from infectionssuggesting that there are risks associated with decreasing the bodys immune response. Canakinumab is also really expensive: a years supply for heart disease treatment would cost $64,000. But, this trial opens the door for future treatments for patients for whom controlling cholesterol isnt enough to improve heart health.

Read this article:
In a first, scientists may have found a treatment for heart disease that doesn't target cholesterol - Quartz

Read More...

Arthritis: the hidden impact on mental health – The Guardian

August 29th, 2017 2:42 am

Arthritis is an unforgiving condition that doesnt just cause physical pain; for many people it impacts so dramatically on their quality of life that it also causes emotional pain. A study conducted by Revealing Reality for the charity Arthritis Research UK found that a quarter of people with arthritis say they often or frequently feel low or depressed on account of their condition. This comes as no surprise to Dr Tom Margham, who works closely with the charity.

Given that mental health and arthritis are so closely linked, healthcare professionals should not just be treating the physical impact of the condition, but also the knock-on effect on mental health, he says.

The invisibility of arthritis means its often misunderstood, making it harder for people living with the condition to find support.

Olivia Belle, Arthritis Research UKs director of external affairs, agrees: Most people underestimate the effects arthritis can have on a persons life. We are working to lift the lid on the reality of living with the condition so that people can live better lives and get the help they need whether that be empathy, treatments or support with their mental health.

The classic symptoms a swollen knee, painful ankles, burning pains in my joints started when I was 17. For the next three years, while studying to be a nurse, I suffered painful flare-ups every few weeks. When I was given a diagnosis of rheumatoid arthritis (RA) in 2010, damage to my joints had already occurred. I went through three knee operations in as many years, all of which left me housebound and in a cast for months.

By 2014, I was working as a clinical assistant at a hospital in London. When I had to resign a year later after taking yet more time off for surgery and recuperation, I was and still am devastated. I got another job as a receptionist but I had to leave that, too. Whenever I thought things were going OK, Id need another operation and then Id be back home again, stuck in bed recuperating. Ive had a total of eight operations and Im awaiting a date for my ninth surgery.

Every day, I wear an ankle and foot brace, and my palms are blistered from using crutches. It upsets me that friends arent supportive. When I say Im in too much pain to meet up, they just go out without me; I would really love it if they came over, and we ordered a takeaway and watched a movie together. It doesnt seem fair that Im in my bedroom clutching a knee full of fluid that feels like molten lava, trying to make some kind of sense out of whats happening to me, while everyone else is out having fun and getting on with their lives.

I live at home with my dad; I dont think hes really grasped the seriousness of my illness and my mum is in India looking after my grandmother. I havent even told the rest of my family how bad things are.

I recently flew to America to visit relatives. I had to get away from the four walls of my bedroom and the endless trips to hospital. I did struggle with the travel and Im paying the price for my adventure now with a huge flare up of RA but it was worth it to feel like I had a life again, albeit it only for a few weeks.

To find out how arthritis affects us all, please visit: arthritisresearchuk.org/jointproblem

Go here to see the original:
Arthritis: the hidden impact on mental health - The Guardian

Read More...

New Ibuprofen health ALERT: Painkiller raises blood pressure in arthritis sufferers – Express.co.uk

August 29th, 2017 2:42 am

The warning was issued yesterday by scientists during a conference in Barcelona on cardiovascular disease.

Delegates were told new research has revealed that ibuprofen one of the most widely prescribed drugs in the world increased blood pressure more than other non-steroidal antiinflammatory drugs (NSAIDs).

The over-the-counter tablet is often the choice for millions in the UK who suffer from the agony of arthritic pain every day.

Researchers at the University Heart Centre in Zurich studied a number of pain relief drugs, which included ibuprofen, naproxen and celecoxib and found a pronounced risk of increased blood pressure in the ibuprofen users, adding to the risk of heart disease and stroke.

The study clearly demonstrates that NSAIDs, particularly ibuprofen, may be not as safe as previously thought

Frank Ruschitzka - Professor of cardiology

Investigator Frank Ruschitzka, professor of cardiology and head of the department at the centre in Switzerland, warned: The study clearly demonstrates that NSAIDs, particularly ibuprofen, may be not as safe as previously thought.

Patients receiving ibuprofen had a 61 per cent higher incidence of de novo hypertension [high blood pressure] compared to those receiving celecoxib.

Researchers had found that celecoxib produced a slight decrease in blood pressure while naproxen caused a relatively small increase.

They warned the findings would have the greatest clinical significance for the elderly, who have a high prevalence of arthritis and hypertension.

GETTY - STOCK IMAGE

Prof Ruschitzka advised: Patients with osteoarthritis and arthritis should continue to consult their doctor before taking NSAIDs and clinicians need to weigh the potential hazards of worsening blood pressure control when considering the use of these agents.

He said that since decreasing blood pressure by a small amount could lower both stroke and heart mortality by 10 per cent and seven per cent respectively, the findings were particularly significant.

In the UK, 10 million people suffer from arthritis with 8.5 million of these with the most common form, osteoarthritis, caused when the cartilage that cushions movement in the joints is worn away.

Currently around 400,000 people in Britain suffer from rheumatoid arthritis, an autoimmune disease in which the bodys own immune system attacks the bodys joints.

GETTY - STOCK IMAGE

The often crippling condition, which has no cure, causes pain, swelling, stiffness and loss of function in the joints.

It is typically diagnosed in people aged 40 to 70 and affects three times as many women as men.

Arthritis Research UK confirmed ibuprofen was taken by many sufferers but warned them of the dangers.

A spokesman said: Longterm use of NSAIDs, including ibuprofen, can increase the risk of problems with your heart or circulation, especially if you have other risk factors for these conditions.

Getty

1 of 11

Common health myths and old wives' tales

Therefore you shouldnt take ibuprofen for long-term pain relief without seeing your doctor first and you shouldnt take ibuprofen if youre also being prescribed another type of NSAID tablet.

Experts in heart disease, which remains Britains biggest killer and claims the lives of 155,000 people a year, also welcomed the new study.

Professor Jeremy Pearson, associate medical director at the British Heart Foundation, said last night: Patients and doctors must weigh up the risks and benefits of NSAIDs, particularly if you have another long-term health condition such as arthritis.

Although not all of these drugs raise your blood pressure significantly, its important to have a discussion with your doctor about the best treatment for you.

GETTY - STOCK IMAGE

Whether you are being prescribed painkillers like ibuprofen, or buying them over the counter, its important to be aware of the risks and you should always talk to your GP or specialist before you start taking any new medication.

NSAID labels include warnings about potential increases in blood pressure but there is little data on the effects of individual drugs.

Researchers found that achieving blood pressure control in patients with arthritis could avoid thousands of deaths from stroke and coronary heart disease each year.

The findings were yesterday presented to the European Society of Cardiology conference in Barcelona.

Read the original here:
New Ibuprofen health ALERT: Painkiller raises blood pressure in arthritis sufferers - Express.co.uk

Read More...

The UK’s ‘hidden’ disease: ‘Arthritis affects everybody, yet nobody talks about it’ – The Guardian

August 29th, 2017 2:42 am

People talk about arthritis being an invisible condition, says Liam OToole, chief executive of Arthritis Research UK. If you cant see the pain, you cant understand the impact. A study for the charity backs him up: it found eight out of 10 people with arthritis felt society didnt understand their condition because it doesnt look serious.

Yet the scale of the problem is huge. Lives, not just of individuals but of families too, are devastated by the pain, isolation and fatigue wrought by arthritis. Meanwhile, the cost to the NHS and the economy, via lost working days, runs to billions of pounds. Arthritis affects everybody, either directly or indirectly, and yet nobody talks about it, OToole says. While other hidden health problems are frequently discussed, arthritis lags behind in the public consciousness.

Arthritis Research UK wants to change that lifting the lid on arthritis is a crucial part of its overall mission: to create a world free from the impact of the condition. The charity believes that once society understands the true impact of arthritis, people will start working together to find solutions. And with its heritage and expertise, its in a strong position to lead the way.

Each strand of Arthritis Research UKs work plays a key role in its overarching objective. As one of the top five medical research charities in the UK in terms of spending, its currently funding more than 300 active projects up and down the country to develop new treatments, so people with arthritis dont have to live in pain. Its working with politicians, doctors, designers and employers, to ensure the NHS, public services, public spaces and workplaces are better equipped to support those struggling with the condition. And with its constantly evolving information and advice services, it works to assist and reassure them and their loved ones.

Last year alone, the charity spent 21.62m on research. Its focus is threefold: finding a cure for arthritis; prevention of the condition in the first place; and transforming the daily existence of those living with the pain of it. Its renowned for its groundbreaking discoveries, including anti-tumour necrosis factor (TNF) therapy a whole new class of drugs that have changed the lives of people with inflammatory arthritis over the past 15 years, since Arthritis Research UK funded research into the activities of TNF in the 1990s.

Pain itself is a key area for research. We think there is a significant subgroup probably 4 million people who are really struggling, OToole says. This is not the sort of pain most of us experience for a couple of weeks. This is chronic, long-term pain for months, years, decades.

But the problem has been neglected, he believes, because the health service is organised around diseases and disciplines: There isnt much research into pain because it doesnt fit into that [structure], and there wasnt enough funding. We want to be strategic: we need to get clever scientists together to get them interested in pain.

In recent years, the 81-year-old organisation has sought the views of 10,000 people living with arthritis to help shape its work and ensure their voices are heard by the people with the power to make change. Everything we do is informed by people with arthritis, OToole says.

Arthritis Research UK works closely with healthcare professionals and provides them with advice and support on caring for people with arthritis. For example, together with the Royal College of General Practitioners, the charity has developed a free online programme that teaches GPs core skills in arthritis care.

Its also working with the design community to give people with arthritis more opportunities to live independently, creating the inclusively designed products and public spaces that are so desperately needed. A funding and support programme to help budding designers turn their ideas into commercial products, delivered with the Design Council, has already discovered Handy-Fasteners magnetic fasteners to replace fiddly buttons, which can be added to peoples existing clothes. And with the Helen Hamlyn Centre for Design, it has developed kitchen products such as a kitchen anchor to support peeling, grating and chopping, and a cook book that encourages hand exercise through recipes involving techniques like kneading.

Arthritis Research UK wants people with arthritis and their families to feel supported to live well with arthritis, which is why it provides a huge range of free information on its website tailored to the needs of those living with arthritis.

Theres an enormous unmet need for advice and support, OToole says. Arthritis Research UK is now using cognitive computing and the input of 500 people with arthritis to develop an online virtual assistant that will learn to answer hundreds of questions people living with arthritis might have.

The virtual assistant is available 24 hours a day which is important, given that pain often keeps people awake at night, says OToole. So is the fact they may have personal questions theyd be embarrassed to ask a doctor. Sometimes people are in so much pain they cant hold their partners hand, he says. You can imagine what that does to a healthy love life.

For OToole, the way arthritis is overlooked has been brought home most starkly by the interviews the charity has carried out. In all the conversations, weve almost needed to take the lid off and give people permission to talk about it and say: Its not OK, he says. The emotional outpouring you then get is enormous.

To find out how arthritis affects us all, please visit: arthritisresearchuk.org/jointproblem

Read more:
The UK's 'hidden' disease: 'Arthritis affects everybody, yet nobody talks about it' - The Guardian

Read More...

Improving the recognition of anxiety and depression in rheumatoid arthritis – Medical Xpress

August 29th, 2017 2:42 am

A study conducted by Keele University shows that patients with rheumatoid arthritis who are also suffering with anxiety or depression may avoid talking to their GP about their mental health symptoms.

Rheumatoid arthritis is a long-term inflammatory condition which causes joint pain, swelling and deformity. Although 1 in 5 people with rheumatoid arthritis experience anxiety or depression, the study (funded by the Haywood Hospital) found that healthcare providers may not recognise mental health problems; instead prioritising physical health concerns. The research showed that this negative experience of care can lead to patients feeling unable to raise their mood problems in future consultations.

The Haywood Foundation funded the set-up of nurse-led clinics in two North Staffordshire community hospitals, as part of a rheumatoid arthritis annual review. Dr Annabelle Machin, a National Institute for Health Research (NIHR) funded researcher, interviewed patients about their previous experiences of care, understanding of anxiety and depression, and preferences for the management of mood problems.

Some patients interpreted their mood problems as normal because of their rheumatoid arthritis, which prevented them from seeking help. Others reported GP appointments to be anxiety-provoking, or felt that their GP prioritised physical over mental health concerns. Patients felt these potential barriers to the discussion of their mood problems could be overcome through continuity of care, provision of time, and encouragement to attend follow-up appointments by a named GP. Patients experiencing severe anxiety and depression felt that mood problems themselves could be a barrier to self-referral for psychological therapy, suggesting that a GP referral could improve access to care.

There was key input from a patient group, who not only assisted with study design and analysis of the interview transcripts, but also helped to develop an information leaflet, which educates patients about mental health problems and treatments in rheumatoid arthritis. The leaflet is now readily available in the Patient Information and Education Resource Centre (PIER) at the Haywood Hospital.

Lead researcher and academic GP, Dr Annabelle Machin, said, "I would like to thank the NIHR for funding this study, which I hope will promote future discussion of mood problems within rheumatoid arthritis annual reviews, as this could have a great impact on both physical and mental health outcomes for patients".

Explore further: Study examines opioid use in patients with rheumatoid arthritis

More information: Annabelle Machin et al. Improving recognition of anxiety and depression in rheumatoid arthritis: a qualitative study in a community clinic, British Journal of General Practice (2017). DOI: 10.3399/bjgp17X691877

More:
Improving the recognition of anxiety and depression in rheumatoid arthritis - Medical Xpress

Read More...

One Eye, once more: Final Clody’s scramble set Sept. 9 – The Banner-Graphic

August 29th, 2017 2:42 am

Clipped from the sports section of the Oct. 4, 1996, some of the first coverage Clodys One Eye Golf Scramble received in the Banner Graphic still adorns the wall of tournament namesake Terry Clody Clodfelter. Old Hickory Golf Course will host the tournaments final round on Saturday, Sept. 9.

Banner Graphic archive

After 25 years and nearly $200,000 in fundraising, a unique Putnam County tradition is coming to an end.

Clodys One Eye, still touting itself as the worlds only one-eye golf tournament, is set for one last round on Saturday, Sept. 9 at Old Hickory Golf Course.

For the final go-round, organizers are planning a single flight set for 11 a.m.

This is gonna be the final 25 years, organizer and tournament namesake Terry Clody Clodfelter told the Banner Graphic recently.

The rules are straightforward: A four-man best-ball scramble with one mulligan per player available for $5 per person.

The cost is $200 per four-man team. First prize is $300, followed by $200 for second and $100 for third.

The tournament will be followed by a 5 p.m. reception at Greencastle Elks Lodge 1077, 202 S. Indiana St.

All proceeds go to the Riley Childrens Hospital opthalmology department. Through the 2016 scramble, $182,000 has been donated by Clodys One Eye so far.

Oh yes, and there is the little matter of those pesky, little eye patches that make golf so much more challenging.

For a quarter century now, those patches have been teaching otherwise competent golfers how difficult the game can be without depth perception.

It was a lesson that Clodys friends needed 25 years ago when they couldnt stop razzing him for his golfing skills.

When Clody, who has no sight in one eye following a childhood accident, challenged these friends to try golfing with just one eye, a tradition was born.

One of the participants who shall remain nameless borrowed the original set of eye patches from the infirmary at the Putnamville State Farm.

Then, as now, even Clody donned an eye patch, noting that the discomfort of the patch is itself a handicap to comfortably playing the game.

Eight of us started it, Clody noted recently. Threw money in the hat, winner takes all. Five buck winner, five buck loser.

It took a few years for the fundraising for Riley to start. The first three years were for sh**s and grins, as Clody puts it.

During the third year, Tony Sparks said to Clody, You ought to do this for charity.

And so Clody reached out to Dr. Eugene Helveston, who had performed his surgery back in 1972, and the partnership between Clodys One Eye and Riley was born.

Dr. Helveston was the surgeon performing in 1972, Clody said. Between the two of us, we got this all started. He was on the ground floor of the One Eye and hes coming back this year.

Now into his 80s, Helveston has not been at the tournament in several years, so his former patient will be glad to see him.

Im glad hes coming, Clody said. Ive had a lot of conversations with that man over the years.

Itll probably be an emotional, humbling day.

Their 45-year relationship began with a freak accident by a 13-year-old boy. Clody was cutting down a thorn tree and got a thorn in his eye.

Five days later he suffered a cataract.

Five or six months later, his retina detached.

Dr. Helveston performed the surgery that kept Clody from further injury, but he has had no sight in the eye since he was 14.

Clody noted how much has changed since his own accident and surgery.

I think I was there at Riley for six or eight days after the retina surgery, he said. Now they do the retina surgery and send you home that afternoon.

While the general advancement of medicine is certainly a part of such positive changes, Clodys own tournament has helped Riley keep up with those changes.

They have opened their own digital diagnosis eye laboratory with the funds that we produced for them, Clody said.

Here in Putnam County, the funds have also provided juvenile vision screening kits to local schools and even funded eye surgeries for kids in Putnam and Clay counties.

Weve taken care of 10 or 12 kids over the years in unfortunate situations, Clody said. The families would get ahold of me and Id contact Riley. It would take care of 100 percent of the cost.

Even as the tournaments run winds to a close, the Riley connection remains strong. Current ophthalmology chief of staff Dr. David Plager will be in attendance, as will others from Riley.

Clody even recently learned that the One Eye is notable in its long-running support of Riley.

We are the longest-running charitable group to have supported any one department that Rileys ever had, Clody said. I didnt know it.

Brad Alspaugh, who has played in the tournament from the beginning and still serves as a co-organizer, hopes to go out with a bang. While it would be departure from recent years, hes hoping to raise $18,000 to bring the total money to $200,000 over the tournaments history.

To do so, the tournament not only needs participants, but sponsors. All donations are tax deductible.

Anyone interested in playing or a sponsorship may contact Clody at 653-9322, Alspaugh at 653-7273 or Jo Corbitt at 247-9426.

Its not for lack of passion that theyll be calling it quits. Clody still keeps a 1996 Banner Graphic clipping of the fourth-annual event tacked up at his house and can recall how Alspaughs team edged his for the tournament title.

With the teams tied for low score, it went to a chip-off and E.J. Rosengarten placed his just inside of Clodys to give a team that also included Barb Young and Mike Cherry the title.

Its the task of organizing the tournament and subsequent reception at Greencastle Elks Lodge 1077 thats become taxing on organizers.

Its run its course, I think, Clody said. And whos to say it may never kick off again? I know Im tired and the other guys are tired. Maybe somebody will get energetic and start it up again.

He also knows that the tradition of golfing with one eye wont be going anywhere just yet.

Brad and I were talking and we know therell be eight or so of us go out and throw money in the hat, Clody said.

For now, theres still the fun of watching some fool put on an eye patch and try to hit a ball with one eye for the very first time. Clody will be playing this time with his son and 13-year-old grandson, who got his first taste of the One Eye last year.

He was saying, How do you do it? This is stupid, Clody said with a grin. But I know he enjoyed it.

Read the original post:
One Eye, once more: Final Clody's scramble set Sept. 9 - The Banner-Graphic

Read More...

How to know if you damaged your eyes during the eclipse | 9news … – 9NEWS.com

August 29th, 2017 2:42 am

Dr. Jon Pederson, the president of the Colorado Optometric Association, is here to answer your eclipse damage questions.

Josh Hafner, USA TODAY , WXIA 7:29 AM. MDT August 22, 2017

A composite image of the total solar eclipse seen from the Lowell Observatory Solar Eclipse Experience August 21, 2017 in Madras, Oregon. / AFP PHOTO / STAN HONDA (Photo credit should read STAN HONDA/AFP/Getty Images)

If you,like our nation's president, looked directly into Monday's eclipse, you might wonder: Did I just damage my eyes?

Whether by accident or disregard, untold masses looked at the sun with unshielded eyes during the must-see-safely event. By Monday afternoon,peoplewere alreadyfreaking outabouttheir eyesonline.

The sun isn't more damaging to your eyes during asolar eclipse than on any other day. But asOhio optometristMichael Schectertold USA TODAY, the moon's covering makes it a lot less painful to look at it for a lot longer. That makes it tempting for folks to peer over their cardboard eclipse glasses to see "what's really going on," Schecter said.

So how long can you look before getting hurt?Not long,says Jacob Chung, Chief of Opthalmology at New Jersey's Englewood Hospital.

"If you look at it for a second or two, nothing will happen," he said."Five seconds, I'm not sure, but 10 seconds is probably too long, and 20 seconds is definitely too long."

You won't feel any pain if your eyes suffer damage, Chung said, because ourretinas lackpain fibers. Retinas can't heal themselves, either, he said, making permanent damage a possibility.

Any blurry vision won't kick in for a day or two, after the affected area swells "like an egg yolk" Schecter said. It can take months, even a year, for eyes to return to normal, he said if it they do at all.

You would basically get a burn on your central vision," Schecter said.

A2001 studylooked at 45 British patients who viewed the 1999 solar eclipse. While 20 patients claimedsymptoms of affected vision, just five showed damage on their retinas. All five looked at the eclipse for 18 seconds or longer,Slate's Will Oremusnoted.

One way to testat home whether you've damaged your eyes is to print offan Amsler Grid, Schecter said, a tool usedto detect vision problems. Closing each eye separately, focus on the center dot and see whether the surrounding grid appears wavy, splotchy or distorted, he said.

An eye doctor, of course, can properly diagnosewhether you've indeed damaged your eyes.

Contributing: Elyse Toribio of The (Bergen County, N.J.) Record.

Follow Josh Hafner on Twitter:@joshhafner

2017 USATODAY.COM

Originally posted here:
How to know if you damaged your eyes during the eclipse | 9news ... - 9NEWS.com

Read More...

Cannabics Pharmaceuticals Received Positive Report from The Patent Cooperation Treaty Regarding Cannabinoid … – PR Newswire (press release)

August 29th, 2017 2:41 am

This PCT report is a major step in the progress of the patent application which is now being launched into several major countries and territories. The company is securing its achievements through a very active and expanding patent portfolio. Other 2nd. Generation patent applications are in the pipeline and Cannabics Pharmaceuticals is aggressively expanding its patent estate as the company's R&D team continues to break new grounds.

Cannabics Pharmaceuticals has made unique developments in the application of medical cannabis to personalized medicine for cancer patients by providing a high throughput screening System (HTS) able to identify the antitumor effect of cannabis strains for individual patients under treatment.

Dr. Eyal Ballan, CTO of Cannabics Pharmaceuticals noted, "As we progress in the field of cannabinoids and cancer we find the unmet need of personalizing cannabis medicine and fortunate to carry out this mission".

About Cannabics Pharmaceuticals Inc.

Cannabics Pharmaceuticals Inc. (CNBX), a U.S based public company, is dedicated to the development of Personalized Anti-Cancer and Palliative treatments. The Company's R&D is based in Israel, where it is licensed by the Ministry of Health for its work in both scientific and clinical research. The Company's focus is on harnessing the therapeutic properties of natural Cannabinoid formulations and diagnostics. Cannabics engages in developing individually tailored natural therapies for cancer patients, utilizing advanced screening systems and personalized bioinformatics tools.

Disclaimer:

Certain statements contained in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to statements identified by words such as "believes," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, results of clinical trials and/or other studies, the challenges inherent in new product development initiatives, the effect of any competitive products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and/or regulation, potential litigation by or against us, any governmental review of our products or practices, as well as other risks discussed from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our latest 10-Q Report filed on July 17th, 2017. We undertake no duty to update any forward-looking statement or any information contained in this press release or in other public disclosures at any time.

For Further Information, please contact:

Cannabics Pharmaceuticals, Inc. +1-877-424-2429 Info@Cannabics.com http://www.Cannabics.com

View original content with multimedia:http://www.prnewswire.com/news-releases/cannabics-pharmaceuticals-received-positive-report-from-the-patent-cooperation-treaty-regarding-cannabinoid-personalized-screening-of-cancer-cells-300510252.html

SOURCE Cannabics Pharmaceuticals Inc.

Home

Read this article:
Cannabics Pharmaceuticals Received Positive Report from The Patent Cooperation Treaty Regarding Cannabinoid ... - PR Newswire (press release)

Read More...

Integrative medicine plays valuable role in cancer treatment – WHIO

August 28th, 2017 1:45 am

Published: Sunday, August 27, 2017 @ 8:23 PMUpdated: Monday, August 28, 2017 @ 1:11 AMBy: Breaking News Staff

UPDATE @1:12 a.m. (Aug. 28)

An 8-year old child with life threatening injuries was transported to Dayton Childrens Hospital Sunday evening after she was ejected from a vehicle that crashed on U.S. 42, according to a Ohio State Highway Patrol Xenia Post news release.

The child was traveling in a Honda Accord hatchback driven by Andrew T. Willis Jr., 28, of Xenia.

The Honda Accord was traveling at a high rate of speed on on U.S. 42south when a white minivan pulled out from a stop sign on Hedges Road, according to trooper interviews with witnesses.

The Chrysler Town and Country minivan was driven by Clifford Hunt Jr., 70, of Grove City. Hunt and his wife, 66-year-old Donna Hunt, were treated and released at the scene of the crash.

Willis was trapped inside the vehicle before he was freed and flown to Miami Valley Hospital with serious injuries.

The front passenger in the vehicle, Chelsea Willis, a 27-year-old Xenia resident, was also transported to MVH with serious injuries.

Two boys, ages 5 and 3, were also traveling in the back seat of the Honda Accord, and were taken to Dayton Childrens Hospital where they were treated for injuries that were not life threatening, according to OSHP.

UPDATE @ 11 p.m.

Southbound U.S. 42 is back open after it was closed for nearly three hours following an injury crash with multiple vehicles involved.

The Ohio State Highway Patrols Xenia Post is expected to release further information tonight or early Monday about the crash.

FIRST REPORT

Southbound U.S. 42 is closed tonight for a multi-vehicle crash in Xenia Twp.

The serious-injury crash was reported shortly before 8 p.m. at U.S. 42 and Hedges Road. Southbound U.S.42 is closed between Hedges and West Krepps roads.

Several medics and a medical helicopter were called to the scene. The crash is under investigation by the Ohio State Highway Patrols Xenia Post.

See more here:
Integrative medicine plays valuable role in cancer treatment - WHIO

Read More...

Sanford Health clinical trial using stem cells reaches full enrollment – Gears Of Biz

August 28th, 2017 1:44 am

The trial is the first in the United States to offer an FDA-approved adipose-derived stem cell trial for shoulder injuries. The trial opened in Fargo, North Dakota, and Sioux Falls in December 2016. In this trial, ones own adipose stem cells are used to determine if they can repair partial thickness rotator cuff tears.

Participants will be evaluated for a year. Interim data will be submitted to the FDA at the 6-month mark in November. The FDA then has 30 days to decide whether Phase 2 of the trial can proceed. If so, enrollment in that trial will begin in 2018. Sanfords Mark Lundeen, M.D., of Fargo and Jason Hurd, M.D., who is based in Sioux Falls, are the studys principal investigators. Both are orthopedic surgeons.

Reaching full enrollment in this trial is exciting for Sanford Research and our patients, said David Pearce, Ph.D., executive vice president of innovation and research at Sanford Health. We believe in doing everything we can to pioneer and then help develop cutting edge therapies. Research is constantly evolving, and we love being part of that. [Watch a video explainer of the trial here.]

Adipose-derived stem cells are taken from the patients abdominal fat and may help speed up healing or regenerate healthy tissue. This form of therapy is already being used as a standard of care in other countries.

Cell therapy, according to Sanford Health experts, uses the bodys own cells as therapy. Stem cells, in particular, have the ability to repair or regenerate cells that are damaged or killed as the result of injury or disease. Sanford Healths cell therapy techniques focus on adipose-derived stems cells because they can be used in many parts of the body and are easily collected. Adipose stem cells also yield many times more cells than other sources like bone marrow, can be returned to the body quickly and have a low infection rate.

About Sanford Health

Sanford Health is an integrated health system headquartered in the Dakotas. It is one of the largest health systems in the nation with 45 hospitals and nearly 300 clinics in nine states and four countries. Sanford Healths 28,000 employees, including more than 1,300 physicians, make it the largest employer in the Dakotas. Nearly $1 billion in gifts from philanthropist Denny Sanford have allowed for several initiatives, including global childrens clinics, genomic medicine and specialized centers researching cures for type 1 diabetes, breast cancer and other diseases. For more information, visit sanfordhealth.org.

Read the rest here:
Sanford Health clinical trial using stem cells reaches full enrollment - Gears Of Biz

Read More...

New report shares details about Europe’s nanomedicine market – WhaTech

August 28th, 2017 1:44 am

The global nanomedicine market size was estimated at USD XX billion in 2017. Technological advancements coupled with relevant applications in early disease diagnosis, preventive intervention, and prophylaxis of chronic as well as acute disorders is expected to bolster growth in this market.

Nanotechnology involves the miniaturization of larger structures and chemicals at nanometric scale which has significantly revolutionized drug administration, thus influencing adoption of the technology through to 2022.

Download Sample Pages @www.kminsights.com/request-sample-33081

Expected developments in nanorobotics owing to the rise in funding from the government organizations is expected to induce potential to the market. Nanorobotics engineering projects that are attempting to target the cancer cells without affecting the surrounding tissues is anticipated to drive progress through to 2022.

Ability of the nanotechnology to serve in diagnostics as well as the therapeutic sector at the same time as a consequence of its characteristic principle to is anticipated to augment research in this sector. Furthermore, utilization of DNA origami for healthcare applications is attributive for the projected growth.

The global nanomedicine market is segmented based on modality, application, indication, and region. Based on application, it is classified into drug delivery, diagnostic imaging, vaccines, regenerative medicine, implants, and others.

On the basis of indication, it is categorized into oncological diseases, neurological diseases, urological diseases, infectious diseases, ophthalmological diseases, orthopedic disorders, immunological diseases, cardiovascular diseases, and others. Based on modality, it is bifurcated into treatments and diagnostics.

This report studies sales (consumption) of Nanomedicine in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, the top player coveringAffilogicLTFNBergmannstrostGrupo PraxisBiotechrabbitBraccoMaterials Research?CentreCarlina technologiesChemConnectionCIC biomaGUNECIBER-BBNContiproCristal TherapeuticsDTIEndomagneticsFraunhofer ICT-IMMTecnaliaTeknikerGIMACIMDEAIstec CNRSwedNanoTechVicomtechVITO NV

The global market is driven by emerging technologies for drug delivery, increase in adoption of nanomedicine across varied applications, rise in government support & funding, growth in need for therapies with fewer side effects, and cost-effectiveness of therapies. However, long approval process and risks associated with nanomedicine (environmental impacts) restrain the market growth.

In addition, increase in out-licensing of nanodrugs and growth of healthcare facilities in emerging economies are anticipated to provide numerous opportunities for the market growth.

Download Sample Pages @www.kminsights.com/request-sample-33081

Read the rest here:
New report shares details about Europe's nanomedicine market - WhaTech

Read More...

Genetic engineering: upgrading to human 2.0 – T3

August 28th, 2017 1:43 am

There are two ways to upgrade a human - tinker with biology or augment with technology. So when the time comes to upgrade to human 2.0, should we become Bioshock-style splicers or Halo-esque spartans?

This week we look at the science behind a genetic boost.

Science fiction isnt afraid to mess with genetics. Bioshocks ADAM is a syrup of stem cells augmented with plasmids that carry superhuman genetic traits. Preys Neuromod enhances cognitive abilities by splicing alien genetics into viruses delivered directly into the brain through the eyes. And Prototype's Blacklight gets in to cells and tweaks their genetic code, activating and editing dormant sequences.

So how close are we to game-changing genetic upgrades?

(Image: I.C. Baianu et al.)

The genetic revolution started in the 1950s with two wily Cambridge scientists. With data nabbed from colleagues in London, Watson and Crick deciphered the structure of DNA and opened Pandoras box. Since then, the field has moved fast, and it's littered with Nobel Prizes.

By the mid 1970s, scientists had discovered DNA-snipping molecular scissors known as restriction enzymes, and DNA-stitching enzymes called ligases. It became possible to cut and splice the genetic code, stitching components from different organisms to create recombinant DNA.Bacteria were turned into factories, churning out molecules that they were never intended to make, and genetic engineering began in ernest.

(Image: Bethesda)

In the 1980s, everything sped up. Polymerase chain reaction (PCR) was invented, allowing chunks of DNA to be copied millions of times in a matter of hours. And DNA sequencing became automated, enabling the genetic code to be read faster than ever before.

And the next logical step once you can read the genetic code? Read all of it.

In 2003, the Human Genome Project was completed , revealing the recipe for a human in its entirety. All three billion letters and over 20,000 genes. And, what took an international team decades can now be repeated in days.

We've got the manual to make a human being. We have the tools to read, write and edit DNA. Time to get creative.

(Image: Irrational Games/2K Games)

Interested in making fire with your fingers? Bioshock-style plasmids are already here. Every day scientists stuff them with genes and jam them into cells to give them new abilities.

Real-world plasmids are loops of DNA most often found in bacteria, where they carry genes for useful traits like antibiotic resistance. They replicate independently of the main bacterial genetic code and can be swapped between cells like trading cards that upgrade the microbes' abilities.

And, with a molecular toolkit, they can be cut open and edited, carrying thousands of letters of genetic code like miniature trojan horses.

(Image: Minestrone Soup )

Plasmids can force cells to make new molecules or switch the behaviour of their existing genes. Bacteria will make infinite copies of them on demand. And, they can be frozen down and stored for years.

But, they tend stay out of chromosomes, floating about in the cell and never meshing with the host unless some serious selective pressure is applied.

They're good for a temporary upgrade, but maybe not for a permanent human 2.0 changes. Maybe thats why splicers need a constant ADAM or EVE fix to keep their abilities topped up.

(Image: 2K Games)

Looking for something a little more permanent than a plasmid? Augments in Prey are delivered by viruses, a step up in terms of persistence.

Retroviruses (like HIV) stitch their own genetic code into the code of the cells they infect, permanently merging with their host to ensure that their genes remain active generation after generation. Every time the cell copies its own DNA, it copies the viral genes too.

So, scientists stripped them out, snipping away the genes that cause disease and turning them into empty genetic transport vessels.

(Image: Bethesda Softworks)

Like plasmids, these 'viral vectors' can be stuffed with genetic code, but this time theyll stitch the new genes straight into the cell, adding the new trait permanently. This is the tech is used in Prey to deliver alien genetics into human brains.

Trouble is, viruses aren't that picky about where they choose to integrate. And, if they tuck their DNA right in the middle of something important, they can ruin a crucial gene and destroy the cell they've infected. Worse still, inserting into some genes can cause cancer.

Then there's the problem of getting them to infect the right cells. If you want fire at your fingertips, you'd need a virus that knew the difference between a hand and a foot.

Scientists are working on improving the usability of viral vectors, but to achieve true human 2.0 without the unpredictable side effects, we'll probably need a more targeted approach. Enter CRISPR.

(Image: Thomas Splettstoesser)

Bioshock or Prey-style approaches to gene editing work well, but they're fuzzy and they take time. CRISPR delivers precision genetic manipulation, fast.

Here's how it works.

Viruses, known as bacteriophages, inject their genetic code into bacteria, turning the microbes into miniature virus factories. But the bacteria evolved a way to fight back.

When they come under attack, they store strips of viral genetic code in a CRISPR reference library so that they'll have a head start if the virus returns. When it attacks again, they check the library and an enzyme called Cas9 chops out any matching code, stopping the infection in its tracks.

(Image: National Human Genome Research Institute (NHGRI) from Bethesda, MD, USA)

The great thing about CRISPR is that it's programmable. Give Cas9 a 20-letter strip of genetic code to guide it, and it'll chew up any DNA you want. These are quick and cheap to make in the lab, and the sequence can be made to match all kinds of different genes. And, when the cell goes to repair the cut, you can swoop in with any new DNA you want to add.

The technique has the scientific community so excited that it was named 'breakthrough of the year' by Science in 2015. But is the world about to be overrun with splicers?

(Image: Ingrid Moen et al. 2012)

Splicers can make fire with their hands, hurl balls of ice and cling to the ceiling like spiders. Morgan Yu can morph into a cup, superheat plasma and create telekinetic shields. What could we do with CRISPR at our disposal?

So far, scientists have repaired a gene that causes muscular dystrophy in mice, and they're trialling the technique to reprogram immune cells in people with cancer. We're now in a CRISPR arms race as scientists across the world rush to be the first to make a gene editing breakthrough.

(Image: Bethesda)

It's early days, but the tech has a lot of potential. We could edit single letter mistakes in genetic code, switch genes off, turn genes on, make genetic tweaks. Or, best of all, we could borrow genes from other species and smash them into our cells to acquire traits we were never supposed to have, glow in the dark jellyfish genes, anyone?

In 2010, scientists created the first synthetic cell. In 2016, they designed and built a genome. In the future, it's possible that we could design brand new genes of our own.

Let's face it, this is still a dream, but the toolkit to make it happen is there.

We still don't know what all of our DNA is for, let alone what changes we'd need to make to improve it. Good luck finding the right genes to edit if you're looking to make yourself taller, smarter or funnier, let alone inventing one that'll give you wings.

And then there's the issue of inheritance. Editing adult, or 'somatic', cells could change a person Bioshock-style, but editing sperm and eggs, or 'germline' cells, could change a whole species.

At the moment, genetic engineering tech is moving faster than the regulation to control it, and it's got scientists worried. We all saw what happened to Rapture when the brakes were taken off scientific advancement.

Gene editing germline cells is restricted in many countries, including the UK, but in July 2017, Chinese scientists got CRISPR working in human embryos for the first time. It was a huge breakthrough, but out of 86 embryos only 28 were successfully edited, and not all of them ended up with the right gene mod at the end.

Rapture, a city where the artist would not fear the censor, where the scientist would not be bound by petty morality, Where the great would not be constrained by the small! And with the sweat of your brow, Rapture can become your city as well.

Luckily, no-one is trying to take edited human embryos all the way though to birth, yet. But, CRISPR opens a whole can of ethical worms, and if youre in any doubt that human modification is coming, watch this.

Pandora's box is open, and we're betting humans of the future will be genetically augmented, but it isn't the only way our species could upgrade. Come back next week when we'll be looking at tech and what it'd take to join the ranks of Halo's Master Chief or Deus Ex's Adam Jensen.

Originally posted here:
Genetic engineering: upgrading to human 2.0 - T3

Read More...

Around the web: Concerns with human genetic engineering, Gary … – American Enterprise Institute

August 28th, 2017 1:43 am

Should we welcome human genetic engineering? Tyler Cowen

If you could directly alter your kids genetic profile, what would you want? Its hard to know how the social debate would turn out after years of back and forth, but I was dismayed to read one recent research paper by psychologists Rachel M. Latham and Sophie von Stumm. The descriptive title of that work, based on survey evidence, is Mothers want extraversion over conscientiousness or intelligence for their children. Upon reflection, maybe that isnt so surprising, because parents presumably want children who are fun to spend time with.

Would a more extroverted human race be desirable, all things considered? I genuinely dont know, but at the very least I am concerned. The current mix of human personalities and institutions is a delicate balance which, for all of its flaws, has allowed society to survive and progress. Im not looking to make a big roll of the dice on this one.

Amazon robots bring a brave new world to the warehouse The Financial Times

Another way to look at US wage growth The Financial Times

The robot tax gains another advocate Wired

Kim got the idea of a robot tax from Bill Gates, who mentioned it in an interview in February. Since then, shes been meeting with stakeholdersunions and business types and the likeabout how San Francisco, and California, might explore such a thing.

Among the issues with a robot tax: What is a robot? Even roboticists have a hard time agreeing. Does AI that steals a job count as a robot? (Nope, but youd probably want to tax it like one if youre going to commit to this.) Were still working on what defines a robot and what defines job displacement, Kim says. And so announcing the opening of the campaign committee is going to also allow us to have discussions throughout the state in terms of what the actual measure would look like.

Video: Powerball lotteries and the endowment effect Marginal Revolution

3,700-year-old Babylonian tablet rewrites the history of math The Telegraph

Winner-takes-all effects in autonomous cars Benedict Evans

Transcript: Gary Cohn on tax reform and Charlottesville The Financial Times

FT: So what exactly will you have in the tax bill?

GC: On the personal side, we have protected the three big deductions charitable, mortgage and retirement saving. We want to raise the standard deduction caps and get rid of many of the other personal deductions. We want to get rid of death taxes and estate taxes.

On the business side, we are proposing to get rid of many of the deductions that companies can take right now to lower taxable income. At the moment we start with a high corporate tax rate in America but companies use deductions: what we are trying to do is get everyone to pay at a lower rate. This is a big base-broadening exercise.

Revenue may decline in the medium term but it will then explode for the government. When we grow the economy we will see substantial growth in revenue.

Continued here:
Around the web: Concerns with human genetic engineering, Gary ... - American Enterprise Institute

Read More...

Activists criticise recommendation on GM mustard by Genetic … – The New Indian Express

August 28th, 2017 1:43 am

NEW DELHI: Activists today criticised the biotech regulator GEAC's decision to recommend commercial use of genetically modified mustard in a submission to the environment ministry.

Coalition for a GM-Free India said it is no coincidence that credible committees are asking to stop the introduction of GM crops.

Their comments came a day after a parliamentary panel said that no GM crop should be introduced in India unless the bio-safety and socio-economic desirability is evaluated in a "transparent" process and an accountability regime is put in place.

The department-related parliamentary standing committee on science and technology and environment and forest chaired by Congress leader Renuka Chowdhury made its recommendations in its 301st report on 'GM crop and its impact on environment'.

The panel's comment came in the wake of India's GM crop regulator Genetic Engineering Appraisal Committee (GEAC) recently recommending the commercial use of genetically modified mustard in a submission to the environment ministry.

The coalition said the latest report is a reiteration in many ways of what earlier committees like the Parliamentary Standing Committee on Agriculture (2012 and 2013) had said as well as the majority report of the Supreme Court's Technical Expert Committee (2013).

"The fact that certain unacceptable lacunae are being pointed out again and again by neutral, independent committees in the law-making and judicial wings of our democracy clearly shows that there are serious problems with transgenic crops as well as their regulation.

"While the government is claiming that it is yet to take a decision with regard to GM mustard 'environmental release', it is clear that this GM food crop does not stand scrutiny under the parameters recommended by the Parliamentary Committee," the coalition said in a statement.

Some of the findings and consequent recommendations of the committee are a "strong indictment" on the approach of the various concerned ministries including the Ministry of Environment, Health and Agriculture with regard to GM crops, the coalition said.

It said the report also acknowledges the rejection of GM crops by state governments.

"The report clearly exposes how poor and unreliable the Indian regulatory regime is, in addition to exposing the lies of GM proponents including within the government.

"It is worrisome that there are no strong policy shifts happening despite repeated exposures of the failures of the Indian biotech regulation," the coalition said.

The Coalition also demanded an inquiry into the "farcical" recommendation of the GEAC for GM mustard environmental release, to "expose the anti-national elements" therein.

The Coalition said the GEAC should be immediately dissolved and its approvals and clearances annulled.

"The report keeps alive our faith in the Parliamentary processes, and we urge the Supreme Court also to take note of this report," the Coalition said.

Excerpt from:
Activists criticise recommendation on GM mustard by Genetic ... - The New Indian Express

Read More...

Roberts: Healthy vision habits make clear sight an everyday event – Greeley Tribune

August 28th, 2017 1:42 am

The "Great American Solar Eclipse" of 2017 was a momentous occasion.

Millions of Americans flocked to cities along the path of the eclipse to witness this rare astronomical event the first total solar eclipse to cross the continental United States from coast to coast in nearly 100 years. For weeks before the eclipse, scientists, medical professionals, the media and more strongly cautioned sky watchers to protect their vision with ISO-certified glasses, as the sun's intense rays could permanently damage the eyes of spectators. By all accounts, Americans paid heed and were able to safely witness the sun disappearing behind the moon.

As executive director of the National Association of Vision Plans, I hope everyone here in Colorado will remember both the event itself and the need to protect your vision. Although the eclipse has come and gone, protecting your eyes should remain a constant focus for you and your family.

Long exposure to everyday UV radiation can lead to serious eye problems, including damage to the retina and loss of vision. Solar radiation has been linked with developing cataracts or macular degeneration later in life. Children's eyes are particularly susceptible to damage, as they receive up to three times more sun exposure than adults.

Vision health is essential to your overall health. Here in Colorado like the rest of the country managed vision care benefits enable individuals to more frequently visit their eye doctor and make sure they have proper vision correction. Managed vision care benefits make access to care possible, reduce patient costs, drive loyal patients into eye doctor offices, identify serious eye and chronic diseases early and ensure patients practice healthier vision behavior.

In fact, more than 87 percent of Americans with benefits plan to get an eye exam in the next 12 months. And patients are four times more likely to seek professional eye care services from an eye care professional when offered vision benefits that cover both an eye exam, as well glasses and or contact lenses.

Many Colorado employers understand the return on investment of managed vision care for their employees. As a result, the vision care industry is growing and innovating at a pace unmatched by most health care sectors both here in the Centennial State and nationwide. More than 80 percent of U.S. employers now offer vision as part of a standard benefit package to employees.

National Association of Vision Plans is committed to seeing Coloradans and Americans across the country put their vision benefit to use. If you don't already have a vision care plan through your employer, I encourage you to explore that option or your options for participating in an individual vision care plan.

The next full solar eclipse is scheduled for just seven years down the road in April 2024. Regular visits to your preferred eye care professional between now and then is the best way for you to ensure you and your family are ready to see it all.

Julian Roberts is the Executive Director of the National Association of Vison Care Plans, the unified voice for the managed vision care industry promoting the value managed vision care brings to U.S. healthcare. Find out more at http://www.navcp.org.

Original post:
Roberts: Healthy vision habits make clear sight an everyday event - Greeley Tribune

Read More...

Martin Newell: My new clarity of vision marks the end of a four-year battle for my sight – Express.co.uk

August 28th, 2017 1:42 am

HILARY LAZELL

It was a mundane return for me to the paradise of sight.

It was the moment when I noticed, eight yards from my writing desk, that for the first time in two years, I could see the central heating boiler and all of its pipes.

To someone who, months earlier, could hardly read a newspaper or see his granddaughters face from more than two feet away, the appliance looked beautiful.

The new clarity of vision marked the end of a four-year battle for my sight.

More was to come.

Days later, while cycling along a country lane, overlooking a river estuary with its patchwork of surrounding farmlands, a strange feeling of awe and gratitude came over me.

I realised that this vista, redolent of a Constable painting, dear to me for decades, had been restored to me at last.

The minor surgical procedure that preceded the return of my sight was the last and simplest of eight operations I had undergone since 2013.

I had not, up until just after my 60th birthday, been much of a drain upon the NHS resources: a few cuts and bruises incurred while gardening, the odd tumble from a bicycle.

Then, one winter morning, while standing on a railway platform, a friend looked at me and asked, Whats wrong with your eye?

HILARY LAZELL

Nothing, I replied uneasily.

Nonetheless, I made a hasty appointment with an optician.

Upon testing me he told me that my interocular pressure was rather high and immediately referred me to the local eye hospital.

After more tests I was diagnosed with a detached retina and thus began a series of operations, during which time further complications arose, now involving both eyes.

Untreatable glaucoma, numerous different eye drops, a retinal tear in my other eye and, finally, the spectre of blindness loomed darkly over me.

Fifty or so years ago I would probably have lost nearly all of my sight.

Advances in the field of eye medicine, however, have been such that much of my sight has been restored.

Now, whether you are religious or not, these medical teams are probably the closest thing on earth that many of us are likely to come to God.

Sight, the emperor of the senses, is something that many of us take for granted.

Yet, when it is taken away, in any measure at all, you dont half know about it.

Our NHS Ophthalmology teams dont, perhaps, always receive either the acclaim accorded to certain other medical departments but they are no less sterling for that.

Eye problems are on the increase in Britain.

One of the reasons is the UKs obesity epidemic.

GETTY - STOCK IMAGE

Being severely overweight can lead to diabetes.

This in turn leads to problems such as diabetic retinopathy, macular degeneration and cataracts.

The cause of my own problems is still unknown since I didnt have any other health problems, although I did have a rather lively, if not knockabout, younger life.

At its worst, during the dark months of last winter, my depleted sight was only functioning with the help of magnifying glasses, strong reading spectacles, extra-bright reading lights and the assistance of an audio typist to transcribe my work.

At one point, shortly after an operation, my depth perception was badly affected and during a poetry performance, for the first time ever, I fell off a stage, cracking my ribs in the process.

1 of 10

Id failed to see where the stage ended and the floor began.

This was demoralising and I became mildly depressed, a thing that I had to fight hard to keep at bay.

Last spring, when the team at my local Ophthalmology department saw my sight had deteriorated further, they swung into action, arresting my chronic glaucoma by implanting a special draining device in my left eye.

Finally, a few weeks ago, they deemed the cataract in my good eye ready for removal.

When, about 24 hours after surgery, the sight came flooding back into my right eye, on a bright summer day, it was almost overwhelming, both physically and emotionally.

Id become so accustomed, by now to reduced vision that I hadnt realised quite how much of it was missing.

GETTY - STOCK IMAGE

Suddenly I could see not only the books upon my shelves but their titles too.

I could recognise people in the street again.

Friends whod guessed my predicament had taken to waving at me and calling my name if they saw me.

When out walking after dark, car headlights and street lamps resembled a scary firework display.

Weeks later, the novelty of having my sight back, even if at present it is in only one eye, still hasnt worn off.

If I have anything to say about my experience, it is this: Do have regular eye check-ups and if youre prescribed drops, take them.

A nurse told me that it is disheartening how many patients neglect to do so.

Dont be afraid of surgery, the idea of it is far more frightening than the actual experience, which usually involves discomfort more than pain.

I will not go anywhere this year. I want to stay here and enjoy the colours of an English autumn.

Its been a very long time.

See the article here:
Martin Newell: My new clarity of vision marks the end of a four-year battle for my sight - Express.co.uk

Read More...

Eye doctors say patients concerned eclipse damaged vision – WSB Atlanta

August 28th, 2017 1:42 am

by: Wendy CoronaUpdated: Aug 23, 2017 - 7:10 PM

ATLANTA - Two days after the eclipse, eye doctors are getting phone calls from people who think they may have damaged their vision from looking at the rare solar event.

Channel 2 Action News and WSBTV.com brought you extensive coverage of the big event, including several warnings about how looking at the sun could damage your vision.

Dr. David Ross, of Ross Eyecare Group in Buckhead, said, Within 3 to 5 days, if damage was going to occur, it has occurred.

Two days after the eclipse, eye doctors are getting phone calls from people who think they may have damaged their vision. WSB-TV

Ross has seen post-eclipse damage before. A partial eclipse in Georgia in 1984 brought two cases of vision damage to his attention from unprotected viewing.

They were very fortunate that, although their vision was blurred for several months, they did fully recover their visual acuity, he said.

Since Monday's eclipse, Ross has fielded calls and seen another couple of patients who feared for their eyesight.

RELATED STORIES:

Luckily, neither one of them had any documentable damage, but we're not out of the woods yet, he said.

Ross said theres a three-to-five-day window of unfortunate opportunity for you to realize something is wrong.

Ross Eyecare Group sent out more than 15,000 emails to patients and their families to warn of the dangers of watching the eclipse without proper protection or with counterfeit eclipse glasses.

On a retinal scan, Ross showed how if the retina gets burned, you would have blurring, a distortion, or a complete gap in the center portion of everything you look at. That would happen in varying degrees depending on the damage.

The two cases Ross has seen since Monday have had their tests come back with undetectable damage.

Whether or not you can recover from damage varies for every person. It could range from just a little blurring for a few days, (or) few weeks and comes back to perfectly normal, to vision that never recovers, Ross said.

Ross urges people to wear UV protective sunglasses and to do exercise that has cardiovascular benefits which help your eyesight. He also encourages regular full eye exams and recommends them for children, too.

2017 Cox Media Group.

Follow this link:
Eye doctors say patients concerned eclipse damaged vision - WSB Atlanta

Read More...

SMART PARENTING: Poor eyesight, clear vision – New Straits Times Online

August 28th, 2017 1:42 am

Not having perfect eyesight should not hinder you from a successful, fulfilling life.

LAST weekend, I was invited to give a motivational talk to members of the Kuala Lumpur and Selangor Albinism Association (KLSAA), of which I am also adviser.

Albinism, according to Wikipedia, is a congenital disorder characterised by complete or partial absence of pigment in the skin, hair and eyes. It is associated with a number of vision defects such as photophobia, nystagmus, and amblyopia.

Not having perfect eyesight (as some KLSAA members demonstrated) should not hinder you from a successful, fulfilling life. One such person is Siti Hajar Ismail, a final year Masters student from the Malaysian Technology University. She spoke briefly about her journey which was by no means, an easy one. In primary school, she couldnt see the blackboard even when she sat in the front row. To copy the teachers notes, she had to rely on other students. Yet she scored As in all her UPSR examination subjects.

Siti Hajar then went on to study in one of the most prestigious boarding schools in the country. Again, she relied on others to catch up with what was taught in the classrooms. She admitted to feeling envious of other students who were able to be active, but she quickly turned things around by focusing on her strengths, not her weaknesses.

She discovered that she was a self-smart person viz, one who understands feelings, emotions and the inner self, a realisation which led her to pursue a degree in psychology. Amazingly, amidst all the difficulties and seemingly impossible challenges, she thrived. Today, Siti Hajar is almost done with her Masters degree, and soon on her way to a PhD (she is well on course to be the first Malaysian albino to obtain a doctorate).

Another person who shared her story was current KLSAAA president Nurulhuda Mohamad. Like Siti Hajar, she engaged a friend to read to her what the teachers wrote on the whiteboard. She also focused on her interpersonal skills to overcome all other limitations. She is now a teacher who can speak four languages Malay, English, Arabic and Thai. How awesome is that?

Another inspiring person I met was the founder and former KLSAA president, Maizan Mohd Salleh. She had to work very hard and overcome all odds to become the first albino lawyer in the country. Today, she is the proud owner of a thriving firm, Maizan & Co.

During the talk, I spoke about the power of vision and the strength of character to overcome the challenges hurled at us. All great leaders are known for their equally great visions: The ability to think long-term and create steps to get there.

A visionary person is someone who can think creatively while balancing it with logic and common sense. Strategic thinking skills are also a very strong trait he or she possesses. Visionary people are in touch with their external environment as well as their inner self and can see how success looks and tastes like. I saw a lot of that in the albinos who shared their stories that day; they may lack good eyesight, but their vision is clearer than ever.

Zaid Mohamad coaches and trains parents to experience happier homes and more productive workplaces. Reach him at zaid@smartparents.com.my

Read more here:
SMART PARENTING: Poor eyesight, clear vision - New Straits Times Online

Read More...

Page 926«..1020..925926927928..940950..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick